Showing results (71-80 of 526) with videos related to
Sort By:
Pageof 53
Virology|January 15, 2013
Impact of viral attachment factor expression on antibody-mediated neutralization of flavivirusesChristopher J Obara, Kimberly A Dowd, Julie E Ledgerwood, et al.Cell Host & Microbe|September 10, 2008
Structural insights into the mechanisms of antibody-mediated neutralization of flavivirus infection: implications for vaccine developmentTheodore C Pierson, Daved H Fremont, Richard J Kuhn, et al.Virology|April 4, 2015
Shake, rattle, and roll: Impact of the dynamics of flavivirus particles on their interactions with the hostRichard J Kuhn, Kimberly A Dowd, Carol Beth Post, et al.Journal of Virology|April 29, 2004
RhoA-derived peptide dimers share mechanistic properties with other polyanionic inhibitors of respiratory syncytial virus (RSV), including disruption of viral attachment and dependence on RSV GPhilip J Budge, Yeqiang Li, Judy A Beeler, et al.Plos One|January 12, 2016
Phenotype and Hierarchy of Two Transgenic T Cell Lines Targeting the Respiratory Syncytial Virus KdM282-90 Epitope Is Transfer Dose-DependentKaitlyn M Morabito, Noam Erez, Barney S Graham, et al.Journal of Virology|May 27, 2011
Structure of respiratory syncytial virus fusion glycoprotein in the postfusion conformation reveals preservation of neutralizing epitopesJason S McLellan, Yongping Yang, Barney S Graham, et al.NPJ Vaccines|April 20, 2023
An optimized messenger RNA vaccine candidate protects non-human primates from Zika virus infectionBrooke Bollman, Naveen Nunna, Kapil Bahl, et al.Virology|July 9, 2009
Human antibody titers to Epstein-Barr Virus (EBV) gp350 correlate with neutralization of infectivity better than antibody titers to EBV gp42 using a rapid flow cytometry-based EBV neutralization assayJunji Sashihara, Peter D Burbelo, Barbara Savoldo, et al.The Journal of Infectious Diseases|May 7, 2021
Limited Flavivirus Cross-Reactive Antibody Responses Elicited by a Zika Virus Deoxyribonucleic Acid Vaccine Candidate in HumansKatherine E Burgomaster, Bryant M Foreman, Maya A Aleshnick, et al.The Journal of Infectious Diseases|March 15, 2011
A West Nile virus DNA vaccine utilizing a modified promoter induces neutralizing antibody in younger and older healthy adults in a phase I clinical trialJulie E Ledgerwood, Theodore C Pierson, Sarah A Hubka, et al.Pageof 53